12:00 AM
Dec 04, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Testosterone tablet: Began Phase III trial

Columbia Laboratories Inc. (COB), New York, N.Y.
Product: Testosterone tablet
Business: Metabolic
Therapeutic category: Hormone replacement
Target: Androgen receptors
Description: Bioadhesive progressive hydration buccal...

Read the full 116 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >